Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30743077 | 1.00 | BCL2L1 (0.41) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL26293051 | 0.86 | ALDH1A1 (0.35) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL14798097 | 0.82 | GPR3 (0.48) | MCL1MAPTRAB9ALMNANPC1 | |
| SCHEMBL17166770 | 0.82 | CYP1A2 (0.47) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL20960180 | 0.81 | ESR1 (0.37) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL30743078 | 0.81 | BCL2L1 (0.39) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL812518 | 0.80 | BCL2L1 (0.50) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL21315911 | 0.80 | CYP1A2 (0.39) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL12433612 | 0.78 | MAPT (0.41) | BCL2L1MCL1MAPTRAB9ALMNA | |
| SCHEMBL20156869 | 0.78 | MAPT (0.41) | BCL2L1MCL1MAPTRAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117250292-A | Separation and analysis method of heteroatom compounds in petroleum geological sample and application thereof | 中国石油天然气股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-20230234937-A1 | INDENOAZANAPHTHALENES | MERCK PATENT GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234937-A1 | INDENOAZANAPHTHALENES | NQO1, CYP2D6, SQOR | BCL2L1 4577/4885MCL1 3665/4885MAPT 2276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.